WOLLERAU, Switzerland, January 7, 2011 /PRNewswire/ -- Shield Holdings AG (Shield), the independent specialty pharmaceutical company focused on the development and commercialisation of late-stage hospital pharmaceuticals, today announces that Carl Sterritt, Chief Executive Officer, will present at the Biotech Showcase Conference on Wednesday 12 January, 2011 at 14:30 PST/ 22:30 GMT at the Parc 55 Wyndham Union Square Hotel in San Francisco, California.
Shield Therapeutics To Present At The Biotech Showcase 2011
Related articles
- Shield Therapeutics Signs Agreement With AOP Orphan For ST10-021
- Shield Therapeutics Raises EUR8.2 Million From Inventages Venture Capital Via Series A Institutional Round
- SuperNova Diagnostics(R) To Present At Biotech Showcase(TM) 2011 During J.P. Morgan Healthcare Conference January 10-13
- Shield Therapeutics Initiates AEGIS 1 And AEGIS 2 Phase 3 Studies Of ST10
- AMT To Supply CGMP Manufacturing To Consortium Led By Institut Pasteur For Clinical Development Of Gene Therapy For Rare Genetic Disorder In Children
Comments